О. М. Мазур

CLINICAL AND LABORATORY CRITERIA FOR THE PERSONALIZATION OF ANTICOAGULANT THERAPY IN PATIENTS WITH SEVERE COVID-19

Introduction. Severe COVID-19 is associated with endothelial dysfunction, immunothrombosis, and coagulopathy, which contribute to thrombotic complications and mortality. Despite the widespread use of anticoagulant therapy, the optimal strategy for dose selection and treatment escalation in severe disease remains debate...